# Individualized Response-adaptive Radiation Dose Prescription in HNC Based on MRI

> **NCT05160714** · PHASE1 · UNKNOWN · sponsor: **University Hospital Tuebingen** · enrollment: 24 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **RADIATION:** Real-time ADC-guided response adaptive Boost in HNC

## Key facts

- **NCT ID:** NCT05160714
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2023-03-30
- **Final completion:** 2025-03-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2022-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05160714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05160714, "Individualized Response-adaptive Radiation Dose Prescription in HNC Based on MRI". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05160714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*